TerrAscend (TSNDF) Consolidated Net Income (2021 - 2026)
TerrAscend (TSNDF) reported Consolidated Net Income of -$1.2 million for Q1 2026, up 74.48% year-over-year from -$673434.6 in Q1 2025, and down 128.59% quarter-over-quarter from $4.1 million in Q4 2025.
TerrAscend (TSNDF) Consolidated Net Income (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Consolidated Net Income data on file, last reported at -$1.2 million in Q1 2026.
- Consolidated Net Income for Q1 2026 came in at -$1.2 million, up 74.48% year-over-year; the trailing twelve-month figure through Mar 2026 was -$53.4 million (down 5.3% YoY), and the FY2025 annual result was -$56.8 million, down 9.78% from the prior year.
- Consolidated Net Income slipped to -$1.2 million in Q1 2026 per TSNDF's latest filing, from $4.1 million in the prior quarter.
- Over five years, Consolidated Net Income peaked at $4.1 million in Q4 2025 and troughed at -$54.7 million in Q4 2023.
- A 5-year average of -$12.0 million and a median of -$4.6 million in 2025 frame the typical range for Consolidated Net Income.
- On a YoY basis, Consolidated Net Income climbed as much as 110.13% in 2025 and fell as far as 86977.08% in 2025.
- A 5-year view of Consolidated Net Income shows it stood at -$10.6 million in 2022, then tumbled by 417.02% to -$54.7 million in 2023, then rose by 25.74% to -$40.6 million in 2024, then soared by 110.13% to $4.1 million in 2025, then tumbled by 128.59% to -$1.2 million in 2026.
- Business Quant data shows TSNDF's Consolidated Net Income at -$1.2 million in Q1 2026, $4.1 million in Q4 2025, and -$14.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -114,733.81 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | TerrAscend | - | - | 34.60 Mn | -1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.18 Mn |
| Dec 31, 2025 | 4.11 Mn |
| Sep 30, 2025 | -14.65 Mn |
| Jun 30, 2025 | -41.70 Mn |
| Mar 31, 2025 | -4.60 Mn |
| Dec 31, 2024 | -40.59 Mn |
| Sep 30, 2024 | -5.58 Mn |
| Jun 30, 2024 | 48,000.00 |
| Mar 31, 2024 | -14.85 Mn |
| Dec 31, 2023 | -54.66 Mn |
| Sep 30, 2023 | -232,000.00 |
| Jun 30, 2023 | -621,000.00 |
| Mar 31, 2023 | -3.59 Mn |
| Dec 31, 2022 | -10.57 Mn |
| Sep 30, 2022 | -10.42 Mn |
| Jun 30, 2022 | -2.70 Mn |
| Mar 31, 2022 | -2.26 Mn |
| Dec 31, 2021 | 3.59 Mn |
| Sep 30, 2021 | 55.84 Mn |
| Jun 30, 2021 | -29.66 Mn |